Skip to main content
20 Years Of Helping Australians To Make The Best Decisions About Medicines And Medical Tests

20 Years Of Helping Australians Make Better Decisions About Medicines, Medical Tests And Other Health Technologies.

Log in

Sign up

Don't miss out on the latest news, evidence and CPD opportunities on medicines and medical tests - sign up today.

My account

Log in details

My subscriptions

Add subscriptions

My favourites

RADAR

RADAR provides health professionals with timely, independent evidence-based information on new drugs and medical tests and changes to listings on the Pharmaceutical Benefits Scheme and Medicare Benefits Schedule.

Latest full reviews View all

Tenofovir with emtricitabine for HIV pre-exposure prophylaxis (PrEP) 

  • 17 Jul 2018
  • 10 min read

The first pharmacological option for pre-exposure prophylaxis of HIV, now widely available through general practice. 

Insulin glargine 300 IU/mL solution (Toujeo) for diabetes mellitus

  • 15 Jun 2018
  • 7 min read

Insulin glargine 300 IU/mL solution (Gla-300) is a basal insulin, administered subcutaneously once daily.

Requesting the new Cervical Screening Test: what providers need to know

  • 1 Dec 2017
  • 8 min read

From 1 December 2017, pathology MBS items for cervical screening will change.

Grazoprevir with elbasvir (Zepatier): fixed-dose combination for chronic hepatitis C genotypes 1 and 4

  • 21 Apr 2017
  • 13 min read

The first interferon-free, oral antiviral treatment option for chronic genotype 4 HCV infection

Latest In Brief View all

Adrenaline autoinjector (Emerade) now available 

  • 10 Jul 2018
  • 2 min read

New adrenaline (epinephrine) autoinjectors on PBS

  • 15 Jun 2018
  • 3 min read

Varenicline (Champix) now Authority required (streamlined) 

  • 7 Nov 2017
  • 6 min read

Ustekinumab (Stelara) PBS listed for severe Crohn’s disease

  • 26 Oct 2017
  • 4 min read

Sofosbuvir/velpatasvir for hepatitis C virus infection

  • 25 Oct 2017
  • 4 min read

Wrap Up

April 2016 new listings wrap-up

  • 1 Apr 2016
  • 4 min read